Wearable devices are provided herein including wearable defibrillators, wearable devices for diagnosing symptoms associated with sleep apnea, and wearable devices for diagnosing symptoms associated with heart failure. The wearable external defibrillators can include a plurality of ECG sensing electrodes and a first defibrillator electrode pad and a second defibrillator electrode pad. The ECG sensing electrodes and the defibrillator electrode pads are configured for long term wear. Methods are also provided for using the wearable external defibrillators to analyze cardiac signals of the wearer and to provide an electrical shock if a treatable arrhythmia is detected. Methods are also disclosed for refurbishing wearable defibrillators. Methods of using wearable devices for diagnosing symptoms associated with sleep apnea and for diagnosing symptoms associated with heart failure are also provided.

Devices and methods for generating synthetic cardio-respiratory signals from one or more ballistocardiogram (BCG) sensors. A method for determining item specific parameters includes obtaining ballistocardiogram (BCG) data from one or more sensors, where the one or more sensors capture BCG data for one or more subjects in relation to a substrate. For each subject, the captured BCG data is pre-processed to obtain cardio-respiratory BCG data. The cardio-respiratory BCG data is sub-sampled to generate the cardio-respiratory BCG data at a cardio-respiratory sampling rate conducive to cardio-respiratory signal generation. The sub-sampled cardio-respiratory BCG data is cardio-respiratory processed to generate a cardio-respiratory parameter set. A synthetic cardio-respiratory signal is generated from at least the cardio-respiratory parameter set and a cardio-respiratory event morphology template. A condition of the subject is determined based on the synthetic cardio-respiratory signal.

A vibrotactile stimulation device intended to be applied against a body medium (MC) to be stimulated, produced in the form of a functional unit, comprising a vibrating effector suitable for applying, to said medium, pulses of mechanical vibrational energy, and a controller for controlling the effector according to stimulation rules. The functional unit further houses a first electrode suitable for cooperating with at least one second electrode separated from the first electrode in order to supply signals representative of a cardiac activity and a muscular activity on the medium to be stimulated, said controller being sensitive to cardiac activity and muscular activity signals in order to influence the stimulation. The stimulation device may be used for body stimulation in combating sleep apnea, with improved detection.

Methods and systems for remote sleep monitoring are provided. Such methods and systems provide non-contact sleep monitoring via remote sensing or radar sensors. In this regard, when processing backscattered radar signals from a sleeping subject on a normal mattress, a breathing motion magnification effect is observed from mattress surface displacement due to human respiratory activity. This undesirable motion artifact causes existing approaches for accurate heart-rate estimation to fail. Embodiments of the present disclosure use a novel active motion suppression technique to deal with this problem by intelligently selecting a slow-time series from multiple ranges and examining a corresponding phase difference. This approach facilitates improved sleep monitoring, where one or more subjects can be remotely monitored during an evaluation period (which corresponds to an expected sleep cycle).

Intraoral appliances are disclosed that provide electrical stimulation to tissue in a patient's oral cavity in a manner that reduces apnea events during sleep. A representative appliance can induce a current or currents through tissue and/or anatomical structures in a manner that maintains upper airway tone and/or patency.

A system includes an electronic circuit, a memory, and a control system. The electronic circuit is coupled to a conduit. The conduit may be configured to deliver pressurized air. A portion of the electronic circuit has a first electrical property that is configured to change based at least in part on movement of the portion of the electronic circuit. The memory stores machine-readable instructions. The control system includes one or more processors configured to execute the machine-readable instructions. Data associated with the first electrical property of the electronic circuit is received. The received data is analyzed. Based at least in part on the analysis, it is determined that the first electrical property of the electronic circuit has changed. Responsive to the determination that the first electrical property of the electronic circuit has changed, it is determined that the conduit is moving or has moved.

An example method includes receiving one or more physiological signals; detecting an apnea event based on the one or more physiological signals; determining that the apnea event cannot be characterized as one of a normal, OSA (obstructive sleep apnea), CSA (central sleep apnea), or combination OSA/CSA event; and outputting an electrical stimulation as a default based on determining that the apnea event cannot be characterized as a normal event, an OSA event, a CSA event, or combination OSA/CSA events.

A method includes applying, via a respiratory therapy system, initial therapy settings for a user during a first sleep session in which the user uses the respiratory therapy system. First physiological data, which is received from one or more sensors, is generated during the first sleep session. Modified therapy settings are applied, via the respiratory therapy system, during a second sleep session of the user. Second physiological data is received from the one or more sensors. The second physiological data is generated by the one or more sensors during the second sleep session. A set of sleep-related parameters is determined based on changes between the first physiological data and the second physiological data. One or more of a recommended therapy or recommended therapy settings is determined based on the set of sleep-related parameters.

A healthcare apparatus includes a ballistocardiogram (BCG) sensor configured to sense a ballistocardiogram signal of a subject, a camera configured to acquire a color facial image, and a processor configured to detect a region of interest (ROI) from the color facial image, to detect a first color image of a forehead area to acquire a first black and white image, to detect a second color image of a cheek area to acquire a second black and white image, to apply the first and second black and white images to a predetermined trained algorithm model to output a remote photoplethysmography (rPPG) signal waveform of the subject, to calculate a first heart rate from the BCG signal waveform, to calculate a second heart rate from the remote PPG signal waveform, and to output a heart rate of the subject based on the first heart rate and the second heart rate.

In certain example embodiments, an air delivery system includes a controllable flow generator operable to generate a supply of pressurized breathable gas to be provided to a patient for treatment and a pulse oximeter. In certain example embodiments, the pulse oximeter is configured to determine, for example, a measure of patient effort during a treatment period and provide a patient effort signal for input to control operation of the flow generator. Oximeter plethysmogram data may be used, for example, to determine estimated breath phase; sleep structure information; autonomic improvement in response to therapy; information relating to relative breathing effort, breathing frequency, and/or breathing phase; vasoconstrictive response, etc. Such data may be useful in diagnostic systems.